Alexion Pharmaceuticals Analysts Recommendations and Consensus

Alexion Pharmaceuticals Inc -- USA Stock  

USD 121.33  0.86  0.71%

The current analyst and expert consensus on Alexion Pharmaceuticals is Buy with 7 hold recommendations. The current projected target price consensus is 160.5 with 16 analysts opinions. One of the most common ways Alexion Pharmaceuticals analysists use to provide buy or sell recommendation to public are conference calls analysis and financial statements evaluations. Some experts can also talk to Alexion Pharmaceuticals vendors, executives, and/or customers. Alexion Pharmaceuticals recommendation module provides expert sentiment on the projected Alexion Pharmaceuticals target price to derive its highest and lowest estimates based on target price standard deviation of 24.314. Check also Macroaxis Advice on Alexion Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

Alexion Pharmaceuticals Target Price Consensus

Number of Opinions21
Lowered Outlook0
Raized Outlook0
Macroaxis Recommendation   Exposure   Valuation

Current Price

Alexion Pharmaceuticals Market Quote
Low Price119.42Odds
High Price122.11Odds


Target Price

Analyst Consensus On Target Price
Low Estimate120.0Odds
High Estimate217.0Odds
Number of Analysts16
Standard Deviation24.314


Alexion Pharmaceuticals Analysit Ratings

Average Consensus